Reuters logo
BRIEF-AstraZeneca announces positive results for new antibiotic
August 19, 2014 / 6:25 AM / 3 years ago

BRIEF-AstraZeneca announces positive results for new antibiotic

LONDON, Aug 19 (Reuters) - AstraZeneca Plc

* Announces positive top-line results from phase III programme of CAZ-AVI

* AstraZeneca today announced positive top-line results from RECLAIM-1 and RECLAIM-2, the pivotal Phase III studies investigating the potential of the antibiotic ceftazidime-avibactam (CAZ-AVI) as a treatment for hospitalised adult patients with complicated intra-abdominal infections. Source text for Eikon: Further company coverage: (Editing by Neil Maidment)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below